Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 55,465 | N/A | 103,065 | 65,172 | 30,136 |
| Depreciation Amortization | 2,372 | N/A | 6,635 | 4,455 | 2,211 |
| Income taxes - deferred | -588 | N/A | 5,020 | 5,899 | 2,224 |
| Accounts receivable | -3,379 | N/A | -55,834 | -29,851 | -9,260 |
| Accounts payable and accrued liabilities | 613 | N/A | 2,097 | 3,434 | 945 |
| Other Working Capital | 13,806 | N/A | -42,091 | -27,157 | 3,989 |
| Other Operating Activity | 22,193 | 0 | 91,974 | 51,518 | 21,111 |
| Operating Cash Flow | $90,482 | $N/A | $110,866 | $73,470 | $51,356 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,265 | N/A | -8,582 | -7,008 | -2,461 |
| Purchase Of Investment | -60,142 | N/A | -281,774 | -239,264 | -126,903 |
| Sale Of Investment | 56,846 | N/A | 299,395 | 207,230 | 124,359 |
| Investing Cash Flow | $-8,561 | $N/A | $9,039 | $-39,042 | $-5,005 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 791 | N/A | 25,506 | 23,903 | 8,616 |
| Common Stock Repurchased | -102,316 | N/A | -124,705 | -79,883 | -46,199 |
| Other Financing Activity | 14 | 0 | 5,265 | 3,623 | 463 |
| Financing Cash Flow | $-101,511 | $N/A | $-93,934 | $-52,357 | $-37,120 |
| Exchange Rate Effect | 504 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 104,073 | N/A | 86,352 | 86,352 | 86,352 |
| End Cash Position | 84,987 | N/A | 112,323 | 68,423 | 95,583 |
| Net Cash Flow | $-19,086 | $N/A | $25,971 | $-17,929 | $9,231 |
| Free Cash Flow | |||||
| Operating Cash Flow | 90,482 | N/A | 110,866 | 73,470 | 51,356 |
| Capital Expenditure | -5,265 | N/A | -8,582 | -7,008 | -2,461 |
| Free Cash Flow | 85,217 | 0 | 102,284 | 66,462 | 48,895 |